Frankfurt - Delayed Quote EUR

Gubra A/S (PI3.F)

Compare
86.60
-3.20
(-3.56%)
At close: January 10 at 6:14:27 PM GMT+1
Currency in DKK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
205,005.00
205,005.00
199,381.00
255,326.00
172,301.00
Cost of Revenue
90,069.00
90,069.00
101,636.00
89,445.00
79,949.00
Gross Profit
114,936.00
114,936.00
97,745.00
165,881.00
92,352.00
Operating Expense
162,603.00
162,603.00
99,033.00
77,207.00
76,487.00
Operating Income
-47,667.00
-47,667.00
-1,288.00
88,674.00
15,865.00
Net Non Operating Interest Income Expense
4,894.00
4,894.00
7,244.00
-1,732.00
-1,483.00
Pretax Income
-42,904.00
-42,904.00
6,259.00
87,100.00
13,681.00
Tax Provision
1,620.00
1,620.00
1,949.00
19,161.00
989.00
Net Income Common Stockholders
-44,524.00
-44,524.00
4,310.00
67,938.00
12,692.00
Diluted NI Available to Com Stockholders
-44,524.00
-44,524.00
4,310.00
67,938.00
12,692.00
Basic EPS
-2.90
--
0.26
4.16
0.78
Diluted EPS
-2.90
--
0.26
4.16
0.78
Basic Average Shares
15,170.73
--
16,349.70
16,349.70
16,349.70
Diluted Average Shares
15,170.73
--
16,349.70
16,349.70
16,349.70
Total Expenses
252,672.00
252,672.00
200,669.00
166,652.00
156,436.00
Net Income from Continuing & Discontinued Operation
-44,524.00
-44,524.00
4,310.00
67,938.00
12,692.00
Normalized Income
-44,524.00
-44,524.00
4,310.00
67,938.00
12,692.00
Interest Income
4,694.00
4,694.00
204.00
6.00
2.00
Interest Expense
4,890.00
4,890.00
1,520.00
1,686.00
1,366.00
Net Interest Income
4,894.00
4,894.00
7,244.00
-1,732.00
-1,483.00
EBIT
-38,014.00
-38,014.00
7,779.00
88,786.00
15,047.00
EBITDA
-28,064.00
-28,064.00
14,664.00
98,901.00
24,439.00
Reconciled Cost of Revenue
90,069.00
90,069.00
101,636.00
89,445.00
79,949.00
Reconciled Depreciation
9,950.00
9,950.00
6,885.00
10,115.00
9,392.00
Net Income from Continuing Operation Net Minority Interest
-44,524.00
-44,524.00
4,310.00
67,938.00
12,692.00
Normalized EBITDA
-28,064.00
-28,064.00
14,664.00
98,901.00
24,439.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 4/5/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LT4.F Liquidia Corporation
12.00
+0.42%
 
2CL.F BridgeBio Pharma, Inc.
27.97
-1.86%
 
BV3.F Bavarian Nordic A/S
26.60
-1.48%
 
ASEP.CN ASEP Medical Holdings Inc.
0.0500
0.00%
 
I9SA.HA Verona Pharma PLC
42.20
-9.44%
 
FYB.F Formycon AG
62.50
+1.63%
 
ABVX.PA ABIVAX Société Anonyme
6.47
+2.21%
 
FYB.DE Formycon AG
62.70
+1.46%
 
5CV.MU CureVac NV
4.0800
+3.82%
 
0QF.F Moderna, Inc.
41.08
-4.00%